ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

0RGI Cosmo Pharmaceuticals Nv

126.90
0.00 (0.00%)
May 09 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Year End December 30 2022 20152016201720182019202020212022
EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)
Total Revenue 60.61M67.66M66.44M64.67M63.25M66.8M65.89M103.99M
Operating Income -16.06M21.01M-15.5M-22.07M-17.37M1.96M28.3M28.06M
Pre Tax Income 254.29M27.49M-32.43M-17.46M-21.3M-6.93M24M24.47M
Net Income 248.19M19.34M-32.45M-18.11M-24.42M-7.9M21.67M17.23M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 17.2141.371-0.9-0.502-0.677-0.2190.6010.321
EBIT 250.3M21.01M-15.5M-22.07M-17.37M1.96M28.3M28.06M
EBITDA -7.57M24.05M-11.96M-17.59M-11.62M8M37.94M41.91M

Your Recent History

Delayed Upgrade Clock